UPDATE: Gilead Sciences (GILD) PT Lowered to $69 at Wells Fargo as CRL Creates Distance From Competition
Wells Fargo analyst Jim Birchenough lowered the price target on Gilead ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)